Addition of a progestin for 10-12 days every month to
cyclic estrogen replacement therapy during menopause is recommended because the progestin:
A. Prevents osteoporosis
B. Prevents irregular bleeding
C. Blocks increased risk of endometrial carcinoma
D. Both ‘B’ and ‘C’ are correct
cyclic estrogen replacement therapy during menopause is recommended because the progestin:
A. Prevents osteoporosis
B. Prevents irregular bleeding
C. Blocks increased risk of endometrial carcinoma
D. Both ‘B’ and ‘C’ are correct